Skip to main content

Abstract

Loiasis, also known as African eye worm is a vector-borne parasitic disease caused by the filarial nematode Loa loa and transmitted by the bite of tabanid vectors (Chrysops dimidiate) from the genus Chrysops. The real burden of the disease is not known, but L. loa remains wrongly classified as a benign disease. Loiasis exists exclusively in Africa where it is mainly focalized in the big areas of Central Africa. The prevalence of the disease rarely exceeds 30 % in endemic communities; however, the disease has become important because of the serious adverse events which occur in some heavily infected patients after treatment with Mectizan for onchocerciasis or lymphatic filariasis. The life cycle of the parasite takes about 10 days in the vector (intermediate host) and about 3 months in humans (definite host). The passage of the adult worm in the bulbar conjunctiva is the classic manifestation of loiasis. Other manifestations are common migratory transient oedema (Calabar swellings). Both of these are used in the clinical diagnosis, complemented by microscopy for microfilaria. Rare but serious manifestations of Loa loa such as encephalitis, glomerular damage, retinal damage, endomyocardial fibrosis, albuminuria and hydrocele may also occur. Both surgical removal of adult worms and chemotherapy are used for managing L. loa. Currently Diethylcarbamazine (DEC), Mectizan®, mebendazole (MBZ) and albendazole (ALB)) are effective in varying degrees against mf and/or adult L. loa, while further research is needed to improve the efficacy of ALB in the management of L. loa.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Abel L, Ioly V, Jeni P, Carbon C, Bussel A (1986) Apheresis in the management of loiasis with high microfilariaemia and renal disease. Br Med J 292:24

    Article  CAS  Google Scholar 

  • Akue JP, Hommel M, Devaney E (1997) High levels of parasite-specific IgG1 correlate with the amicrofilaremic state in Loa loa infection. J Infect Dis 175:158–163

    Article  PubMed  CAS  Google Scholar 

  • Akue JP, Hommel M, Devaney E (1998) IgG subclass recognition of Loa loa antigens and their correlation with clinical status in individuals from Gabon. Parasite Immunol 20:387–393

    Article  PubMed  CAS  Google Scholar 

  • Bonnin H, Moretti G (1950) Preuves cliniques et biopsiques de l’action léthale d’un dérivé de la pipérazine sur la filaire Loa loa adulte. Bull Soc Pathol Exot 33:4

    Google Scholar 

  • Boussinesq M (2006) Loiasis. Ann Trop Med Parasitol 100:715–731

    Article  PubMed  CAS  Google Scholar 

  • Boussinesq M (2012) Loiasis: new epidemiologic insights and proposed treatment strategy. J Travel Med 19:140–143

    Article  PubMed  Google Scholar 

  • Boussinesq M, Gardon J (1997) Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection. Ann Trop Med Parasitol 91:573–589

    Article  PubMed  CAS  Google Scholar 

  • Burbelo PD, Ramanathan R, Klion AD, Iadarola MJ, Nutman TB (2008) Rapid, novel, specific, high-throughput assay for diagnosis of Loa loa infection. J Clin Microbiol 46:2298–2304

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Carme B, Mamboueni JP, Copin N, Noireau F (1989) Clinical and biological study of Loa loa filariasis in Congolese. AmJTrop Med Hyg 41:331–337

    CAS  Google Scholar 

  • Carme B, Boulesteix J, Boutes H, Puruehnce MF (1991a) Five cases of encephalitis during treatment of loiasis with diethylcarbamazine. AmJTrop Med Hyg 44:684–690

    CAS  Google Scholar 

  • Carme B, Ebikili B, Mbitsi A, Copin N (1991b) Therapeutic trial with ivermectin in loiasis with medium and high microfilaremia. Ann Soc Belg Med Trop 71:47–50

    PubMed  CAS  Google Scholar 

  • Chandenier J, Pillier-Loriette C, Datry A, Rosenheim M, Danis M, Felix H, Nozais JP, Gentilini M (1987) Value of cytapheresis in the treatment of loaiasis with high blood microfilaria levels. Results in 7 cases. Bull Soc Pathol Exot 80:624–633

    CAS  Google Scholar 

  • Chippaux JP, Ernould JC, Gardon J, Gardon-Wendel N, Chandre F, Barberi N (1992) Ivermectin treatment of loiasis. Trans R Soc Trop Med Hyg 86:289

    Article  PubMed  CAS  Google Scholar 

  • Chippaux JP, Bouchite B, Demanou M, Morlais I, Le Goff G (2000) Density and dispersal of the loaiasis vector Chrysops dimidiata in southern Cameroon. Med Vet Entomol 14:339–344

    Article  Google Scholar 

  • Churchill DR, Morris C, Fakoya A, Wright SG, Davidson RN (1996) Clinical and laboratory features of patients with loiasis (Loa loa filariasis) in the U.K. J Infect 33:103–109

    Article  PubMed  CAS  Google Scholar 

  • Ducorps M, Gardon-Wendel N, Ranque S, Ndong W, Boussinesq M, Gardon J, Schneider D, Chippaux JP (1995) Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin. Bull Soc Pathol Exot 88:105–112

    PubMed  CAS  Google Scholar 

  • Duke BO (1955) The development of Loa in flies of the genus Chrysops and the probable significance of the different species in the transmission of loiasis. Trans R Soc Trop Med Hyg 49:115–121

    PubMed  CAS  Google Scholar 

  • Duke BO (1990) Effect of diethylcarbamazine on adult Loa in monkeys. Ann Trop Med Parasitol 84:387–392

    PubMed  CAS  Google Scholar 

  • Duong TH, Kombila M, Ferrer A, Bureau P, Gaxotte P, Richard-Lenoble D (1997) Reduced Loa loa microfilaria count ten to twelve months after a single dose of ivermectin. Trans R Soc Trop Med Hyg 91:592–593

    Article  PubMed  CAS  Google Scholar 

  • Dupont A, Zue-N’dong J, Pinder M (1988) Common occurrence of amicrofilaraemic Loa loa filariasis within the endemic region. Trans R Soc Trop Med Hyg 82:730

    Article  PubMed  CAS  Google Scholar 

  • Egwang TG, Dupont A, Leclerc A, Akue JP, Pinder M (1989) Differential recognition of Loa loa antigens by sera of human subjects from a loiasis endemic zone. AmJTrop Med Hyg 41:664–673

    CAS  Google Scholar 

  • El Haouri M, Erragragui Y, Sbai M, Alioua Z, Louzi, El Mellouki W, Sedrati O (2001) Cutaneous filariasis Loa Loa: 26 moroccan cases of importation. Ann Dermatol Venereol 128:899–902

    PubMed  Google Scholar 

  • Fain A (1978) Current problems of loaiasis. Bull World Health Organ 56:155–167

    PubMed  PubMed Central  CAS  Google Scholar 

  • Fain A, Maertens K (1973) Notes sur la ponte des microfilaires chez loa loa et sur le degré de maturité des vers en migration. Bull Soc Pathol Exot 66:6

    Google Scholar 

  • Fink DL, Fahle GA, Fischer S, Fedorko DF, Nutman TB (2011a) Toward molecular parasitologic diagnosis: enhanced diagnostic sensitivity for filarial infections in mobile populations. J Clin Microbiol 49:42–47

    Article  PubMed  PubMed Central  Google Scholar 

  • Fink DL, Kamgno J, Nutman TB (2011b) Rapid molecular assays for specific detection and quantitation of Loa loa microfilaremia. PLoS Negl Trop Dis 5:e1299

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Fobi G, Gardon J, Santiago M, Ngangue D, Gardon-Wendel N, Boussinesq M (2000) Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia. Ophthalmic Epidemiol 7:27–39

    Article  PubMed  CAS  Google Scholar 

  • Gardon J, GardonWendel N, DemangaNgangue D, Kamgno J, Chippaux J, Boussinesq M (1997a) Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350:18–22

    Article  PubMed  CAS  Google Scholar 

  • Gardon J, Kamgno J, Folefack G, Gardon-Wendel N, Bouchite B, Boussinesq M (1997b) Marked decrease in Loa loa microfilaraemia six and twelve months after a single dose of ivermectin. Trans R Soc Trop Med Hyg 91:593–594

    Article  PubMed  CAS  Google Scholar 

  • Garin C, Garin JP (1951) Treatment of filariasis from filaria loa by notezine. J Med Bordeaux Sud-Ouest 128:250–252

    CAS  Google Scholar 

  • Gentilini M, Carme B (1981) Treatment of filariases in a hospital setting. Complications – results. Ann Soc Belg Med Trop 61:319–326

    PubMed  CAS  Google Scholar 

  • Gordon RM, Kershaw WE, Crewe W, Oldroyd H (1950) The problem of loiasis in West Africa with special reference to recent investigations at Kumba in the British Cameroons and at Sapele in Southern Nigeria. Trans R Soc Trop Med Hyg 44:11–47

    Article  PubMed  CAS  Google Scholar 

  • Goussard B, Ivanoff B, Beville G, Garin Y (1984) Current aspects of the ELISA technic applied to the serological diagnosis of helminthiasis. Pathol Biol 32:1043–1049

    PubMed  CAS  Google Scholar 

  • Gruntzig J, Gewalt W (1979) Cameroon swelling; infection by the filaria Loa loa. Fortschr Med 97:1932–1937

    PubMed  CAS  Google Scholar 

  • Hawking F (1955) Periodicity of microfilariae of Loa loa. Trans R Soc Trop Med Hyg 49:132–142

    PubMed  CAS  Google Scholar 

  • Hawking F (1977) The distribution of human filariasis throughout the world, part III, Africa. Trop Dis Bull 74:8

    Google Scholar 

  • Holmes D (2013) Loa loa: neglected neurology and nematodes. Lancet Neurol 12:631–632

    Article  PubMed  Google Scholar 

  • Hovette P, Debonne JM, Touze JE, Gaxotte P, Imbert P, Fourcade L, Laroche R (1994) Efficacy of ivermectin treatment of Loa loa filariasis patients without microfilaraemias. Ann Trop Med Parasitol 88:93–94

    PubMed  CAS  Google Scholar 

  • Jimenez M, Gonzalez LM, Carranza C, Bailo B, Perez-Ayala A, Muro A, Perez-Arellano JL, Garate T (2011) Detection and discrimination of Loa loa, Mansonella perstans and Wuchereria bancrofti by PCR-RFLP and nested-PCR of ribosomal DNA ITS1 region. Exp Parasitol 127:282–286

    Article  PubMed  CAS  Google Scholar 

  • Kamgno J, Boussinesq M (2001) Hyperendemic loaiasis in the Tikar plain, shrub savanna region of Cameroon. Bull Soc Pathol Exot 94:342–346

    PubMed  CAS  Google Scholar 

  • Kamgno J, Gardon J, Boussinesq M (2000) Analysis of the prevention of post-ivermectin Loa loa encephalopathy by administration of initial low dose. Med Trop 60:275–277

    CAS  Google Scholar 

  • Klion AD, Nutman TB (2010) Loiasis and Mansonella infections, in Tropical Infectious Diseases: Principles, Pathogens and Practice. Third edition (Guerrant, RL, Walker, DH, Weller, PF, eds). Churchill Livingstone (New York)

    Google Scholar 

  • Klion A, Massougbodji A, Sadeler B, Ottesen E, Nutman T (1991) Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation. J Infect Dis 163:1318–1325

    Article  PubMed  CAS  Google Scholar 

  • Klion AD, Eisenstein EM, Smirniotopoulos TT, Neumann MP, Nutman TB (1992) Pulmonary involvement in loiasis. Am Rev Respir Dis 145:961–963

    Article  PubMed  CAS  Google Scholar 

  • Klion AD, Massougbodji A, Horton J, Ekoue S, Lanmasso T, Ahouissou NL, Nutman TB (1993) Albendazole in human loiasis: results of a double-blind, placebo-controlled trial. J Infect Dis 168:202–206

    Article  PubMed  CAS  Google Scholar 

  • Klion AD, Ottesen EA, Nutman TB (1994) Effectiveness of diethylcarbamazine in treating loiasis acquired by expatriate visitors to endemic regions: long-term follow-up. J Infect Dis 169:604–610

    Article  PubMed  CAS  Google Scholar 

  • Klion AD, Horton J, Nutman TB (1999) Albendazole therapy for loiasis refractory to diethylcarbamazine treatment. Clin Infect Dis: Off Publ Infect Dis Soc Am 29:680–682

    Article  CAS  Google Scholar 

  • Klion AD, Vijaykumar A, Oei T, Martin B, Nutman TB (2003) Serum immunoglobulin G4 antibodies to the recombinant antigen, Ll-SXP-1, are highly specific for Loa loa infection. J Infect Dis 187:128–133

    Article  PubMed  CAS  Google Scholar 

  • Kombila M, Duong TH, Ferrer A, Perret JL, Marion MC, Nguiri C, Gaxotte P, Manfoumbi M, Richard-Lenoble D (1998) Short- and long-term action of multiple doses of ivermectin on loiasis microfilaremia. AmJTrop Med Hyg 58:458–460

    CAS  Google Scholar 

  • Kouam KM, Tchatchueng-Mbougua JB, Demanou M, Boussinesq M, Pion SDS, Kamgno J (2013) Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon. Parasite Vector 6:283

    Article  CAS  Google Scholar 

  • Languillat G, Garin Y, Tursz A, Beauvais B, Lariviere M (1977) Etiological study of low fertility in eastern Gaboon. III. Filarial endemicity (Loa loa, D. perstans). Prevalence of microfilariae in hydroceles (author’s transl). Rev Epidemiol Sante Publique 26:273–282

    PubMed  CAS  Google Scholar 

  • Lebied B (1957) Iconography of the intrasynctial evolution of the Loa loa in Chrysops; preliminary note on the internal and external factors determining the evolutive cycle of Filariata (Scrjabin) in their intermediary hosts. Ann Soc Belg Med Trop 37:641–645

    CAS  Google Scholar 

  • McGarry HF, Pfarr K, Egerton G, Hoerauf A, Akue JP, Enyong P, Wanji S, Klager SL, Bianco AE, Beeching NJ, Taylor MJ (2003) Evidence against Wolbachia symbiosis in Loa loa. Filaria J 2:9

    Article  PubMed  PubMed Central  Google Scholar 

  • Muylle L, Taelman H, Moldenhauer R, Van Brabant R, Peetermans ME (1983) Usefulness of apheresis to extract microfilarias in management of loiasis. Br Med J 287:519–520

    Article  CAS  Google Scholar 

  • Negesse Y, Lanoie LO, Neafie RC, Connor DH (1985) Loiasis: “Calabar” swellings and involvement of deep organs. AmJTrop Med Hyg 34:537–546

    CAS  Google Scholar 

  • Noireau F, Apembet JD, Nzoulani A, Carme B (1990) Clinical manifestations of loiasis in an endemic area in the Congo. Trop Med Parasitol 41:37–39

    PubMed  CAS  Google Scholar 

  • Padgett JJ, Jacobsen KH (2008) Loiasis: African eye worm. Trans R Soc Trop Med Hyg 102:983–989

    Article  PubMed  Google Scholar 

  • Paris L, Datry A, Durepaire R, Felix H, Gaxotte P, Danis M, Gentilini M (1991) Usefulness of ivermectin as initial treatment of loiasis. Presse Med 20:1393–1393

    PubMed  CAS  Google Scholar 

  • Pinder M (1988) Loa loa – a neglected filaria. Parasitol Today 4:279–284

    Article  PubMed  CAS  Google Scholar 

  • Richard-Lenoble D, Kombila M, Rupp EA, Pappayliou ES, Gaxotte P, Nguiri C, Aziz MA (1988) Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections. AmJTrop Med Hyg 39:480–483

    CAS  Google Scholar 

  • Richardson ET, Luo R, Fink DL, Nutman TB, Geisse JK, Barry M (2012) Transient facial swellings in a patient with a remote African travel history. J Travel Med 19:183–185

    Article  PubMed  PubMed Central  Google Scholar 

  • Rodhain F, Rodhain-Rebourg F (1973) A propos de la distribution géographique de la loase. Med Mal Infect 11:8

    Google Scholar 

  • Shookhoff HB, Dwork KG (1949) Treatment of Loa loa infections with hetrazan. AmJTrop Med Hyg 29:589–593

    CAS  Google Scholar 

  • Tabi TE, Befidi-Mengue R, Nutman TB, Horton J, Folefack A, Pensia E, Fualem R, Fogako J, Gwanmesia P, Quakyi I, Leke R (2004) Human loiasis in a Cameroonian village: a double-blind, placebo-controlled, crossover clinical trial of a three-day albendazole regimen. AmJTrop Med Hyg 71:211–215

    CAS  Google Scholar 

  • Toure FS, Egwang TG, Wahl G, Millet P, Bain O, Georges AJ (1997) Species-specific sequence in the repeat 3 region of the gene encoding a putative Loa loa allergen: a diagnostic tool for occult loiasis. AmJTrop Med Hyg 56:57–60

    CAS  Google Scholar 

  • Toure FS, Kassambara L, Williams T, Millet P, Bain O, Georges AJ, Egwang TG (1998) Human occult loiasis: improvement in diagnostic sensitivity by the use of a nested polymerase chain reaction. AmJTrop Med Hyg 59:144–149

    CAS  Google Scholar 

  • Toure FS, Leroy EM, Mavoungou E, Egwang TG (1999a) Sequence conservation of repeat 3 region of the gene coding for the 15 kDa polyprotein within human and simian Loa loa. J Med Primatol 28:57–61

    Article  PubMed  CAS  Google Scholar 

  • Toure FS, Mavoungou E, Deloron P, Egwang TG (1999b) Comparative analysis of two diagnostic methods of human loiasis: IgG4 serology and nested PCR. Bull Soc Pathol Exot 92:167–170

    PubMed  CAS  Google Scholar 

  • Tsague-Dongmo L, Kamgno J, Pion SD, Moyou-Somo R, Boussinesq M (2002) Effects of a 3-day regimen of albendazole (800 mg daily) on Loa loa microfilaraemia. Ann Trop Med Parasitol 96:707–715

    Article  PubMed  CAS  Google Scholar 

  • Van Hoegaerden M, Flocard F (1985) Mebendazole treatment of loaiasis. Lancet 1:1278

    Article  PubMed  Google Scholar 

  • Van Hoegaerden M, Ivanoff B, Flocard F, Salle A, Chabaud B (1987) The use of mebendazole in the treatment of filariases due to Loa loa and Mansonella perstans. Ann Trop Med Parasitol 81:275–282

    PubMed  Google Scholar 

  • Védy J, Cahuzac G, Labegorre J (1975) Manifestations oculaires atypiques des filarioses à Loa loa. Méd Armées 3:8

    Google Scholar 

  • Wanji S, Tendongfor N, Esum M, Ndindeng S, Enyong P (2003) Epidemiology of concomitant infections due to Loa loa, mansonella perstans and onchocerca volvulus in rain forest villages of Cameroon. Med Microbiol Immunol 192:15–21

    PubMed  CAS  Google Scholar 

  • Wanji S, Tendongfor N, Nji T, Esum M, Che JN, Nkwescheu A, Alassa F, Kamnang G, Enyong PA, Taylor MJ, Hoerauf A, Taylor DW (2009) Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon. Parasite Vector 2:39

    Article  CAS  Google Scholar 

  • Williams P, Crewe W (1967) Studies on the control of the vectors of loiasis in West Africa. 8. An attempt to control loiasis at Kumba, West Cameroon. Ann Trop Med Parasitol 61:148–158

    PubMed  CAS  Google Scholar 

  • Zoure HG, Wanji S, Noma M, Amazigo UV, Diggle PJ, Tekle AH, Remme JH (2011) The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA). PLoS Negl Trop Dis 5:e1210

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joseph Kamgno .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kamgno, J., Nana-Djeunga, H.C., Kouam-Kenmogne, M. (2016). Loiasis. In: Gyapong, J., Boatin, B. (eds) Neglected Tropical Diseases - Sub-Saharan Africa. Neglected Tropical Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-25471-5_7

Download citation

Publish with us

Policies and ethics